Ada-Icon

Why Was Belviq Discontinued? Answers Inside

Drug Injury

Obesity is a known factor for the development of metabolic syndrome. This is a fancy term that basically means that being overweight may make you prone to illnesses such as diabetes, heart disease and various cancers. To this end, doctors do everything they can to help their overweight patients lose weight, including prescribing medication such as Belviq which has been shown to jump-start weight loss.

Why was Belviq discontinued? If you have been taking Belviq for some time, you may have heard about Belviq being recalled by the FDA early last year. This is due to the increased risk of certain cancers that has been seen in people who have taken Belviq for over 6 months. Failure to warn constitutes legal liability under product liability law, which entitles you to compensation under the law. If you took Belviq and developed cancer, you may be eligible for substantial financial compensation. To learn more about your legal options, please call (773) 825-3605 to speak with a Belviq lawsuits attorney at absolutely no cost to you.

Belviq, manufactured by Eisai Inc., located in San Diego, became the subject of a voluntary FDA recall in February 2020, causing the manufacturer to pull its product from pharmacies all over the country. This was after an 8 year run after it was given approval by the FDA which was contingent on the company continuing to carry out randomized clinical trials in order to see if Belviq had harmful effects on the heart. In the course of performing these trials, it was discovered that rats ingesting a certain amount of Belviq started growing tumors affecting their brains, lungs, colon and pancreas. Upon reviewing patient data, it was discovered that up to 7.7 percent of individuals taking Belviq developed cancer as well.

Belviq Trials Show Increased Cancer Risk

The specific trial was CAMELLIA-TIMI 61 which showed that over 500 out of 12,000 patients developed cancer, compared to only 470 in the placebo group. It was also revealed that 34 individuals had cancer which had spread or metastasized to other organs, compared to just 19 in the placebo group.

In order to qualify for a Belviq lawsuit, you must meet the following criteria:

  • Have been prescribed Belviq or XR after June 2012
  • Are below 70 years
  • You were diagnosed with cancer 6 months after you started taking Belviq
  • You developed colorectal, pancreatic, lung or breast cancer while on or after Belviq

Belviq Lawsuit Help – Call Us Today!

Belviq cancer lawsuits may be heard as a singular Class Action Lawsuit, or they may be divided into various legal jurisdictions and heard individually in the form of multi-district litigation or MDL. If you have burning questions or just want to know how to get started on your claim, please call us NOW at (773) 825-3605 to receive your FREE consultation. Thanks, and we look forward to hearing from you.